Quarterly JM Medical News

Cure JM September 2024 – Virtual Summit

We are pleased to invite all juvenile dermatomyositis healthcare professionals to join us virtually for the latest presentations, sharing clinical best practices to help providers diagnose, treat, and care for juvenile myositis patients.

Cure JM May 2024 – Virtual Symposium

The Cure JM Clinical Care Network hosted our second quarterly virtual symposium of 2024, “Juvenile Dermatomyositis – Advances in Clinical Care, Basic Research, and Translational Studies.” World-leading researchers and clinicians presented sessions on various topics, with the primary goal of enhancing the overall patient and provider experience through collaboration and best practice sharing.

Early Promising Data Presented in Car-T for Myositis

Cabaletta Bio Presents Promising Early Data on CAR-T Therapy for Myositis

We expected to hear promising news about the potential for CAR-T therapy to treat myositis at the Global Conference on Myositis (GCOM).

What we heard was more than promising—it was astounding.

What if I told you that there was a therapy that would “reset” the immune system—virtually eliminating the autoimmune response in myositis that causes inflammation, pain, muscle weakness, and other JM conditions of which we are all too familiar.

Cure JM September 2024 – Virtual Summit

Cure JM May 2024 – Virtual Symposium

Cabaletta Bio Presents Promising Early Data on CAR-T Therapy for Myositis

Join Cure JM

Families

Physicians

Cure JM

Get Involved

Interested in DIY fundraising but need help?

We’re here to help!